can semaglutide prevent dementia Frontiers Focus: After weight loss, Alzheimer's

This points to the existence of an overarching energy regulation phenotype spanning cognitive and physical health disorders [10, 11]

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand names Ozempic and Rybelsus) and chronic weight management (under the brand name Wegovy)

Published research has associated long-term GLP-1 receptor agonist use with an elevated risk of this condition in some patient populations

Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

Data Availability No datasets were generated or analysed during the current study